Cardiovascular Disease in Moorestown, NJ
11 verified cardiovascular disease doctors in Moorestown.
Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New Jersey State Board of Medical Examiners
Dr. Steven Lederman, MD
Cardiovascular Disease
CMS Open Payments· $32.38 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$32.38
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 39th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Steven Lederman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ralph Russo, MD
Cardiovascular Disease
CMS Open Payments· $3,184 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,184
Total received
93
Transactions
20
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Ralph Russo do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jay Sussman, MD
Cardiovascular Disease
CMS Open Payments· $59.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$59.10
Total received
3
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 42th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Jay Sussman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Thomas Galski, DO
Cardiovascular Disease
CMS Open Payments· $1,084 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,084
Total received
40
Transactions
13
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Thomas Galski do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Maria Duca, MD
Cardiovascular Disease
CMS Open Payments· $743.12 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$743.12
Total received
28
Transactions
13
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 69th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Maria Duca do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Samuel Ventrella, MD
Cardiovascular Disease
CMS Open Payments· $613.20 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$613.20
Total received
32
Transactions
10
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 66th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Samuel Ventrella do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anthony Sauerwein, MD
Cardiovascular Disease
CMS Open Payments· $1,432 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,432
Total received
58
Transactions
13
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 78th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Anthony Sauerwein do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jeffrey Namey, MD
Cardiovascular Disease
CMS Open Payments· $1,593 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,593
Total received
70
Transactions
19
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 79th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Jeffrey Namey do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Schimenti, MD
Cardiovascular Disease
CMS Open Payments· $603.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$603.19
Total received
27
Transactions
12
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 66th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Robert Schimenti do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rachit Vakil, MD
Cardiovascular Disease
CMS Open Payments· $19,035 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19,035
Total received
18
Transactions
4
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Rachit Vakil do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Samuel Sauerwein, MD
Cardiovascular Disease
CMS Open Payments· $33.94 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$33.94
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 39th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Samuel Sauerwein do not imply any wrongdoing. Many are meals, education, or research support.